
Full Spine Presentation with PulStar
As a Doctor of Chiropractic, you are undoubtedly on a constant quest to hone your craft and provide your clients with the best treatment possible.
Fill out this form to receive regular expert tips in your inbox!

As a Doctor of Chiropractic, you are undoubtedly on a constant quest to hone your craft and provide your clients with the best treatment possible.

How visualized instrument adjusting can revolutionize your patients’ experience and your practice As a doctor of chiropractic, you strive to provide your patients with the

Recently, I had a flare up from my L5 – S1 herniated disc. When this happens, I know it’s time to get a checkup with

Chiropractic adjusting instruments are quickly becoming one of the fastest-growing forms of chiropractic manipulation today. With these instruments’ ability to offer speed, precision, and efficiency, it’s

Armed with these five steps and the world-wide push for MDs to avoid prescribing opioids, Chiropractors have a new chance to stimulate referrals from Physicians.

Did you know that lower back pain is common among astronauts in space? Chiropractors from the University of Zurich, Dr. Jaap Swanenburg and Dr. Michael

“PulStar Treatment In 45 Cases of Supraspinatus Tendon Calcification,” conducted by researchers at the Benxi First People’s Hospital in China, was published in the Journal

In a 2020 study, 60% of chiropractors report workplace injuries. Most chiropractors altered their treatment techniques to accommodate the injury.

As part of the ongoing R&D by Dr. Evans and his team, the PulStar brand has always represented the newest technologies revolutionizing the field of

Fig.1, above: Measurement set-up, standing, and standing with 50% additional axial load. Research to reduce lower back pain among Astronauts in space You might remember

In a costly study conducted independently from Sense Technology, researchers proved the effectiveness of PulStar when compared to acupressure and verify its ability to lengthen

During re-certification for PulStar in Europe and China, four new clinical studies were found. Two were Randomized Control Trials (RCTs). Both the Department of Surgery,